Hot Topics In Lung Infections An Issue Of Infectious Disease Clinics Of North America

In this issue of Infectious Disease Clinics, guest editors Rachael Lee and Helen W. Boucher bring their considerable expertise to the topic of Lung Infections. Top experts in the field provide important updates on hot topics such as Viral Pneumonias, Infectious Pulmonary Diseases, Infections in Heart and Lung Transplant Recipients, and more. Contains 12 practice-oriented topics including Opportunistic Infections Post-Lung Transplantation: Viral, Fungal, and Mycobacterial; Novel Approaches to Multidrug-Resistant Infections in Cystic Fibrosis; Coronavirus Disease-2019 in the Immunocompromised Host; Novel and Rapid Diagnostics for Common Infections in the Critically Ill Patient; and more. Provides in-depth clinical reviews on lung infections, offering actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

In this issue of Infectious Disease Clinics, guest editors Rachael Lee and Helen W. Boucher bring their considerable expertise to the topic of Lung Infections. Top experts in the field provide important updates on hot topics such as Viral Pneumonias, Infectious Pulmonary Diseases, Infections in Heart and Lung Transplant Recipients, and more. Contains 12 practice-oriented topics including Opportunistic Infections Post-Lung Transplantation: Viral, Fungal, and Mycobacterial; Novel Approaches to Multidrug-Resistant Infections in Cystic Fibrosis; Coronavirus Disease-2019 in the Immunocompromised Host; Novel and Rapid Diagnostics for Common Infections in the Critically Ill Patient; and more. Provides in-depth clinical reviews on lung infections, offering actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

The Guest Editors, coming from the Critical Care Medicine Department in the NIH, are the top thought leaders in the area of infections in critical care. Their topic selections in this issue reflect the most clinically relevant and current information. The issue specifically covers the following topics: Catheter-related bloodstream infections: special considerations in diagnosis in the ICU; Sepsis-How does the new definition help clinicians; Therapeutic drug monitoring of antibiotics; High containment pathogen preparation; Multidrug resistant gram negative infections and enterococcus; Strategies to prevent transmission of resistant organisms; Antibiotic Stewardship: What the intensivist should know; C. Difficile infection in the ICU; Immunocompromised critically ill; Rapid diagnostics: The use of procalcitonin; Respiratory viruses in the ICU: Significance of rhino/rsv updates/adenovirus metapneumovirus; Management of invasive fungal disease in the ICU; Inhaled/Nebulized antibiotics. Infectious disease physicians and intensivists will be armed with the information they need to diagnose and treat patients with infections in the ICU.

UTI Challenges: Beyond the Basics, An Issue of Infectious Disease Clinics of North America, E-Book

Infectious diseases are the leading cause of death globally, particularly among children and young adults. The spread of new pathogens and the threat of antimicrobial resistance pose particular challenges in combating these diseases. Major Infectious Diseases identifies feasible, cost-effective packages of interventions and strategies across delivery platforms to prevent and treat HIV/AIDS, other sexually transmitted infections, tuberculosis, malaria, adult febrile illness, viral hepatitis, and neglected tropical diseases. The volume emphasizes the need to effectively address emerging antimicrobial resistance, strengthen health systems, and increase access to care. The attainable goals are to reduce incidence, develop innovative approaches, and optimize existing tools in resource-constrained settings.

Infection Prevention and Control in Healthcare, Part I: Facility Planning, An Issue of Infectious Disease Clinics of North America, E-Book

In this issue of Infectious Disease Clinics of North America, guest editors Drs. Emily Sydnor Spivak and Sage Greenlee bring their considerable expertise to the topic of Antimicrobial Stewardship: Where We Have Come and Where We Are Going. Throughout the last decade, the field of antimicrobial stewardship has undergone exponential growth due to heightened awareness of antimicrobial use and emerging multidrug-resistant organisms. Additionally, the COVID-19 pandemic highlighted systemic and persistent health disparities in the United States. In this issue, top experts provide a recap of the progress made over the last decade in antimicrobial stewardship and provide direction for next steps in this ever-growing field. Contains 12 practice-oriented topics including antimicrobial stewardship and pandemic preparedness: lessons learned from COVID-19; health equity considerations; antimicrobial stewardship at transitions of care; antimicrobial stewardship in immunocompromised populations; health system and tele-antimicrobial stewardship: the role of building networks; and more. Provides in-depth clinical reviews on antimicrobial stewardship, offering actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

This report considers the biological and behavioral mechanisms that may underlie the pathogenicity of tobacco smoke. Many Surgeon General's reports have considered research findings on mechanisms in assessing the biological plausibility of associations observed in epidemiologic studies. Mechanisms of disease are important because they may provide plausibility, which is one of the guideline criteria for assessing evidence on causation. This report specifically reviews the evidence on the potential mechanisms by which smoking causes diseases and considers whether a mechanism is likely to be operative in the production of human disease by tobacco smoke. This evidence is relevant to understanding how smoking causes disease, to identifying those who may be particularly susceptible, and to assessing the potential risks of tobacco products.